Leaflet: information for the patient
Vaxar Plus 15mg/10mg tablets
Vaxar Plus 30mg/10mg tablets
Vaxar Plus 40mg/10mg tablets
rosuvastatin and ezetimibe
Read this leaflet carefully before starting to take this medicine, as it contains important information for you.
Contents of the leaflet
5 Preservation of Vaxar Plus
Vaxar Plus contains two different active substances in one tablet. One of the active substances is rosuvastatin, which belongs to a group of medicines called statins, and the other active substance is ezetimibe.
Rosuvastatin/ezetimibe tablets are a medicine used to reduce total cholesterol, "bad" cholesterol (LDL cholesterol), and fatty substances called triglycerides that circulate in the blood. Additionally, it raises the levels of "good" cholesterol (HDL cholesterol). This medicine works by reducing cholesterol in two ways: it reduces the cholesterol absorbed in the digestive tract, as well as the cholesterol produced by the body itself.
For most people, high cholesterol levels do not affect how they feel, as they do not produce any symptoms. However, if left untreated, fatty deposits can accumulate in the walls of blood vessels and narrow them.
Sometimes, these narrowed blood vessels can become blocked, cutting off the blood supply to the heart or brain, which can cause a heart attack or stroke. By reducing cholesterol levels, you can reduce your risk of having a heart attack, stroke, or other related health problems.
Rosuvastatin/ezetimibe is used in patients who cannot control their cholesterol levels with diet alone. While taking this medicine, you should follow a cholesterol-reducing diet.
Your doctor may prescribe Vaxar Plus if you are already taking rosuvastatin and ezetimibe at the same dose level.
Rosuvastatin/ezetimibe is used if you have:
This medicine does not help you lose weight.
Do not take Vaxar Plus if:
If you are in any of the above situations (or are unsure), please consult your doctor again.
Additionally, do not take Vaxar Plus 40 mg/10 mg (the highest dose) if:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Vaxar Plus if:
If you are in any of these situations mentioned above (or are unsure): do not take Vaxar Plus 40 mg/10 mg (the highest dose) and consult your doctor or pharmacist before starting to take any dose of Vaxar Plus tablets.
In a small number of people, statins can affect the liver. This is detected by a simple test that detects increased levels of liver enzymes in the blood. For this reason, your doctor will normally perform blood tests (liver function tests) during treatment with Vaxar Plus. It is essential that you visit your doctor for these tests.
While taking this medicine, your doctor will closely monitor you if you have diabetes or are at risk of developing diabetes. You are likely to be at risk of developing diabetes if you have high sugar and fat levels in your blood, are overweight, and have high blood pressure.
Severe skin reactions, including Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with rosuvastatin treatment. Stop using Vaxar Plus and seek medical attention immediately if you notice any of the symptoms described in section 4.
Children and adolescents
Vaxar Plus is not recommended for use in children and adolescents under 18 years of age.
Other medicines and Vaxar Plus tablets
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Inform your doctor if you are taking any of the following medicines:
If you go to the hospital or receive treatment for another illness, tell the medical staff that you are taking Vaxar Plus tablets.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Pregnancy
Do not take Vaxar Plus tabletsif you are pregnant, think you may be pregnant, or plan to become pregnant. If you become pregnant while taking Vaxar Plus tablets, stop taking it immediatelyand inform your doctor. Women should use contraceptive methods during treatment with Vaxar Plus.
Breastfeeding
Do not take Vaxar Plus tabletsif you are breastfeeding, as it is unknown whether the medicine passes into breast milk.
Driving and using machines
Vaxar Plus tablets are not expected to interfere with your ability to drive or use machines. However, some people may feel dizzy after taking Vaxar Plus tablets. If you feel dizzy, consult your doctor before attempting to drive or use machines.
Vaxar Plus tablets contain lactose monohydrate
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.
Vaxar Plus tablets contain sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially, "sodium-free".
Follow the instructions for taking this medicine exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
You should continue to follow a cholesterol-reducing diet and exercise while taking Vaxar Plus tablets.
The recommended daily dose for adults is one tablet of the indicated dose.
Take Vaxar Plus tablets once a day.
You can take it at any time of day, with or without food. Swallow each tablet whole with water.
Take your medicine at the same time every day.
Vaxar Plus tabletsare not suitable for initiating treatment. The start of treatment or dose adjustments, if necessary, should only be done by taking the active substances separately, and once the appropriate doses are adjusted, it is possible to switch to the appropriate dose of Vaxar Plus tablets.
The maximum daily dose of rosuvastatin is 40 mg. This dose is only for patients with high cholesterol levels and a high risk of having a heart attack or stroke, whose cholesterol levels do not decrease sufficiently with 30 mg.
Regular cholesterol level checks
It is essential that you visit your doctor regularly to have your cholesterol levels checked, to ensure that your cholesterol levels have normalized and are maintained at appropriate levels.
If you take more Vaxar Plus tablets than you should
Contact your doctor or the nearest hospital emergency department, as you may need medical assistance.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Vaxar Plus tablets
Do not worry, omit the missed dose and take the next scheduled dose at the planned time. Do not take a double dose to make up for missed doses.
If you interrupt treatment with Vaxar Plus tablets
Consult your doctor if you want to interrupt treatment with Vaxar Plus tablets. Your cholesterol levels may increase again if you stop taking Vaxar Plus tablets.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
It is essential that you know what these adverse effects can be.
Stop taking Vaxar Plus tablets and seek immediate medical attentionif you experience any of the following allergic reactions:
Also, stop taking Vaxar Plus and consult your doctor immediately if you have unusual muscle pains that last longer than expected. In rare cases, this can become a potentially life-threatening muscle injury known as rhabdomyolysis, which causes general discomfort, fever, and kidney problems.
The following terms are used to describe how often adverse effects have been reported:
Very common adverse effects (may affect more than 1 in 10 people)
Common adverse effects (may affect up to 1 in 10 people)
Uncommon adverse effects (may affect up to 1 in 100 people)
Rare adverse effects (may affect up to 1 in 1,000 people)
Very rare adverse effects (may affect up to 1 in 10,000 people, including isolated cases)
Common Adverse Effects
Uncommon Adverse Effects
Rare Adverse Effects
Very Rare Adverse Effects
Jaundice (yellowing of the skin and eyes); liver inflammation (hepatitis); blood in the urine; nerve damage in the legs and arms (such as numbness); memory loss; breast enlargement in men (gynecomastia).
Unknown Frequency
Difficulty breathing; edema (swelling); sleep disturbances, including insomnia and nightmares; sexual dysfunction; depression; respiratory problems, including persistent cough and/or difficulty breathing or fever; tendon injuries; constant muscle weakness; red, raised rash, sometimes with target-shaped lesions (erythema multiforme); muscle sensitivity; gallstones or gallbladder inflammation (which can cause stomach pain, nausea, vomiting),
Severe myasthenia (a disease that causes generalized muscle weakness that, in some cases, affects the muscles used for breathing); ocular myasthenia (a disease that causes weakness of the eye muscles).
Consult your doctor if you experience weakness in your arms or legs that worsens after periods of activity, double vision or drooping eyelids, difficulty swallowing or difficulty breathing.
Reporting Adverse Effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Store in the original packaging to protect it from light. This medicine does not require special storage conditions.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging after "CAD". The expiration date is the last day of the month indicated.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition ofVaxar Plus
The active ingredients are rosuvastatin (as rosuvastatin calcium) and ezetimibe. The tablets contain rosuvastatin calcium equivalent to 15 mg, 30 mg, or 40 mg of rosuvastatin. Each tablet contains 10 mg of ezetimibe.
The other components are: lactose monohydrate, microcrystalline cellulose, sodium croscarmellose, crospovidone type A, povidone K-30, sodium lauryl sulfate, and magnesium stearate.
Appearance of the Product and Package Contents
Vaxar Plus 15 mg/10 mg: Hexagonal, biconvex, uncoated tablet, white to off-white in color, with approximate dimensions of 9 x 8 mm and "E3" engraved on both sides.
Vaxar Plus 30 mg/10 mg: Rectangular, biconvex, uncoated tablet, white to off-white in color, with dimensions of 12 x 6 mm and an "X" engraved on both sides.
Vaxar Plus 40 mg/10 mg: Elliptical, biconvex, uncoated tablet, white to off-white in color, with approximate dimensions of 13 x 6 mm and "E6" engraved on both sides.
This medicine is available in packages of 28, 30, 56, 60, and 90 tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Adamed Laboratorios, S.L.U.
c/ de las Rosas de Aravaca, 31 - 2ª planta
28023 Madrid
Spain
Manufacturer
Adamed Pharma S.A.
Ul. Marszalka Jósefa Pilsudskiego 5
95-200 Pabianice, Lodzkie
Poland
This medicine is authorized in the Member States of the European Economic Areawiththe following names:
Poland: Vaxar Plus
Spain: Vaxar Plus 15mg/10mg tablets
Vaxar Plus 30mg/10mg tablets
Vaxar Plus 40mg/10mg tablets
Date of the last revision of this prospectus: March 2024
Detailed information about this medicine is available on the website of the {Spanish Agency for Medicines and Health Products (AEMPS)} (http://www.aemps.gob.es/)